Researchers to investigate the risk of airborne viruses in buildings

By Nikita Chaurasia  Date: 2020-05-14

Researchers to investigate the risk of airborne viruses in buildings

As the world gradually paces back to normalcy after recuperating from the devastating effects of COVID-19, a research team from DOE’s Lawrence Berkeley National Laboratory (Berkeley Lab) embarked on the quest to study the risk of airborne viruses transmission within buildings and how it can be mitigated.

According to Brett Singer, Head of the Indoor Environment research group, Berkeley Lab, top researchers at their lab are concentrating on developing plans to safely bring people back to work. The organization intends to use its vast expertise in air contaminant and movement removal to inform guidance.

Reportedly, the study hopes to quantitatively understand various risk levels under diverse scenarios of occupancy. The team would also use a combination of experiments and simulations to analyze the transport of aerosols and droplets between and within rooms.

Elaborating on the sets of questions this study is trying to focus on, Tom Kirchstetter, co-lead of the research and director of Energy Analysis and Environmental Impacts Division, Berkeley Lab, revealed that a key question would be “what is the risk of an inhabitant inhaling transmittable virus while being in a building or room with at least one or more infected people?”

Prior studies have established that respiratory fluids are expelled not only while sneezing or coughing, but also while performing routine activities like singing, talking or just by breathing. Whenever an infected patient transmits these respiratory aerosols, it could directly transfer into people who are nearby. This is thought to be the main source of virus transmission.

However, this study intends to understand other aspects of this transmission, i.e. the so-called unknown portion of these aerosols that tends to mix up in the air present in the room, eventually spreading into other adjacent rooms in the complex.

Source Credit: https://newscenter.lbl.gov/2020/05/13/new-research-launched-on-airborne-virus-transmission-in-buildings/

About Author

Nikita Chaurasia     aeresearch.net

Nikita Chaurasia

An accomplished professional in the field of content development, playing with words comes naturally to Nikita Chaurasia. After completing her post-graduate MBA degree in Advertising and PR, Nikita worked across numerous content-driven verticals, undertaking diverse r...

Read More

More News By Nikita Chaurasia

1health to offer two types of COVID-19 testing kits to SkyWest Airlines

1health to offer two types of COVID-19 testing kits to SkyWest Airlines

By Nikita Chaurasia

Leading Testing as a Service (TaaS) provider, 1health, recently announced that it has partnered with SkyWest Airlines, a SkyWest Inc. subsidiary, to provide two types of COVID-19 tests to the airline’s personnel. Mehdi Maghsoodnia, CEO at 1hea...

FBI to remove backdoors from hacked Microsoft Exchange email servers

FBI to remove backdoors from hacked Microsoft Exchange email servers

By Nikita Chaurasia

Following the recent cyber-attack in the US, a court in Houston has reportedly authorized a new FBI operation to copy and eliminate backdoors from large number of Microsoft Exchange email servers across the country. During this hacking event, the hac...

France might ban short domestic flights to reduce its carbon footprint

France might ban short domestic flights to reduce its carbon footprint

By Nikita Chaurasia

French lawmakers recently came to a unanimous decision to ban domestic flights for distances that can be covered by train in over two-and-a-half- hours. The country aims to impose these restrictions in an effort to reduce carbon emissions, even as th...

Kavak secures USD 485 million in funding, eyes Latin America expansion

Kavak secures USD 485 million in funding, eyes Latin America expansion

By Nikita Chaurasia

Kavak, a Mexico-based used-car platform, has reportedly reached a valuation of USD 4 billion after securing USD 485 million during a new funding round. This makes it the fastest-growing as well as the most valued company in Latin America. The latest...

Zydus seeks DCGI approval for PegIFN drug to treat COVID-19 patients

Zydus seeks DCGI approval for PegIFN drug to treat COVID-19 patients

By Nikita Chaurasia

Indian pharmaceutical company Zydus Cadila is reportedly seeking approval from DCGI (Drug Controller General of India) for its PegIFN (Pegylated Interferon Alpha-2b), a hepatitis C drug, to treat COVID-19 patients, after its third phase of clinical t...